fda removes tirzepatide from shortage list GLP-1 Drugs: Sued Over Removing the Drug FDA sets tirzepatide compounding deadlines

In their trials, the 25 mg Wegovy pill produced an average weight loss of 13.6% over 64 weeks, while the 7.2 mg Wegovy injection produced 20.7% over 72 weeks

Common Health Conditions in Seniors and GLP-1 Compatibility Elderly patients frequently have type 2 diabetes, hypertension, or heart diseaseconditions that often improve with GLP-1 therapy

J Neuroinflammation 1:22, PMID: 15527505 Moylan S, Maes M, Wray NR, Berk M (2013) The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications

"FKBP14-related Ehlers-Danlos syndrome: expansion of the phenotype to include vascular complications"